Cardiac arrest due to pulmonary embolism.
Indian Heart Journal · 2018-01-01 · Systematic review
Abstract
Pulmonary embolism (PE) is a potentially life threatening clinical condition that is fairly non-specific in presentation. Massive pulmonary embolism (PE) without cardiac arrest has been associated with a mortality rate of 30%. However, when cardiac arrest ensues, mortality may be as high as 95%. Since outcomes of cardiac arrest following PE are generally dismal, any available potentially life-saving measure must be instituted when the diagnosis of PE is suspected. Despite a lack of randomized controlled trials guiding the management of suspected PE in the cardiac arrest victim, thrombolysis and other therapies have been associated with good outcomes in the handful of published case reports and other small studies.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antithrombotics & thrombolytics · Mortality & survival · Thrombolytics
Related articles
- Intra-arrest systemic thrombolytic therapy during cardiopulmonary resuscitation: a systematic review and meta-analysis of randomized controlled trials. (Resusc Plus, 2026)
- Thrombolytics in Cardiac Arrest from Pulmonary Embolism: A Systematic Review and Meta Analysis. (J Intensive Care Med, 2024)
- Role of adjunct anticoagulant or thrombolytic therapy in cardiac arrest without ST-segment-elevation or percutaneous coronary intervention: A systematic review and meta-analysis. (Am J Emerg Med, 2023)
- Can Systemic Thrombolysis Improve Prognosis of Cardiac Arrest Patients During Cardiopulmonary Resuscitation? A Systematic Review and Meta-Analysis. (J Emerg Med, 2019)
- Thrombolytics for cardiac arrest: case report and systematic review of controlled trials. (Ann Pharmacother, 2010)
- Familial pulmonary embolism in two siblings with first presentation as sudden cardiac arrest: a clinical case report from the Indian subcontinent. (Int J Emerg Med, 2026)